Barbara M. Wirostko, MD, FARVO
Chief Medical Officer, Qlaris Bio Inc.
Dr. Barbara Wirostko is the Chief Medical Officer of Qlaris Bio Inc., after being a cofounder for a successful series A raise. She is Adjunct Professor of Ophthalmology and Biomedical Engineering at the University of Utah Health and serves as Moran’s Resident Research Director. Barbara is a fellowship-trained glaucoma specialist, treats glaucoma and comprehensive ophthalmology patients, specializes in clinical research, and advises drug development for glaucoma pharmaceutical therapies. She is a serial entrepreneur for biotech startups, such as Jade Therapeutics which she co-founded and then for which she served as Chief Medical Officer when it was acquired by EyeGate Pharmaceuticals. As principal investigator, she has received millions in grants from the Department of Defense and National Science Foundation SBIR grants. Her research interests lie in novel glaucoma therapeutics, sustained delivery of therapeutics for ocular pathologies, and better understanding the genetics and associated systemic diseases of exfoliative syndrome, a common cause of open-angle glaucoma.
Dr. Wirostko earned her MD at Columbia University, completed her internship at Hackensack Medical Center, completed her residency in Ophthalmology at Columbia Presbyterian Medical Center’s Edward S. Harkness Eye Institute, and completed her fellowship in Glaucoma at the New York Hospital, Cornell Medical Center (now referred to as New York-Presbyterian / Weill Cornell Medical Center). She is a board-certified ophthalmologist and is a Fellow of the Association of Research in Vision and Ophthalmology (ARVO). Dr. Wirostko has scored in the top 10 percent nationwide for patient satisfaction. Her professional and scientific experience includes serving as associate editor for Ophthalmology Glaucoma, Acta Ophthalmologica, and Journal of Glaucoma. She is an active committee member for ARVO and a scientific advisor for the Glaucoma Foundation, and the Glaucoma Research Foundation and serves on the CIRM Grants Working Group. Her honors include Moran’s Clinical Faculty of the Year Award in 2015 and the Third Annual Distinguished Alumni Award from the Edward S. Harkness Eye Institute, Columbia University. Lastly, Barbara is the founder and Executive Director of a nationally recognized 501c3 supporting young adults with dyslexia, The Joseph James Morelli Legacy Foundation. She lives in Park City, Utah, with her family.